Opus Genetics, Inc. · NASDAQ:IRD
Balyasny Asset Management L.P. reported a 6.64% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P. reported a 6.64% stake in Opus Genetics, Inc., 5,480,210 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.64%
- Shares
- 5,480,210
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 6.64% | 5,480,210 |
| BAM GP LLC | 6.64% | 5,480,210 |
| Balyasny Asset Management Holdings LP | 6.64% | 5,480,210 |
| Dames GP LLC | 6.64% | 5,480,210 |
| Dmitry Balyasny | 6.64% | 5,480,210 |
Source
Related
- Opus Genetics, Inc.
- Balyasny Asset Management L.P.
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · May 15, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Feb 17, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026